These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12019843)

  • 1. Dynamic MRI enhanced with albumin-(Gd-DTPA)30 or ultrasmall superparamagnetic iron oxide particles (NC100150 injection) for the measurement of microvessel permeability in experimental breast tumors.
    Turetschek K; Huber S; Helbich T; Floyd E; Tarlo KS; Roberts TP; Shames DM; Wendland MF; Brasch RC
    Acad Radiol; 2002 May; 9 Suppl 1():S112-4. PubMed ID: 12019843
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model.
    Turetschek K; Roberts TP; Floyd E; Preda A; Novikov V; Shames DM; Carter WO; Brasch RC
    J Magn Reson Imaging; 2001 Jun; 13(6):882-8. PubMed ID: 11382948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs. Gd-DTPA.
    Simon GH; von Vopelius-Feldt J; Wendland MF; Fu Y; Piontek G; Schlegel J; Chen MH; Daldrup-Link HE
    J Magn Reson Imaging; 2006 May; 23(5):720-7. PubMed ID: 16557494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice.
    de Lussanet QG; Backes WH; Griffioen AW; van Engelshoven JM; Beets-Tan RG
    Radiology; 2003 Nov; 229(2):429-38. PubMed ID: 14595147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation.
    Turetschek K; Huber S; Floyd E; Helbich T; Roberts TP; Shames DM; Tarlo KS; Wendland MF; Brasch RC
    Radiology; 2001 Feb; 218(2):562-9. PubMed ID: 11161179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High resolution MRI of MCF7 human breast tumors: complemented use of iron oxide microspheres and Gd-DTPA.
    Furman-Haran E; Margalit R; Grobgeld D; Degani H
    J Magn Reson Imaging; 1998; 8(3):634-41. PubMed ID: 9626879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of the contrast behavior of typical focal hepatic lesions before and after the administration of Gd-DTPA and superparamagnetic iron oxide particles.
    Helmberger T; Holzknecht N; Reiser M
    Acad Radiol; 2002 Aug; 9 Suppl 2():S468-72. PubMed ID: 12188311
    [No Abstract]   [Full Text] [Related]  

  • 8. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and anatomic imaging of tumor vasculature: high-resolution MR spectroscopic imaging combined with a superparamagnetic contrast agent.
    Karczmar GS; Fan X; Al-Hallaq H; River JN; Tarlo K; Kellar KE; Zamora M; Rinker-Schaeffer C; Lipton MJ
    Acad Radiol; 2002 May; 9 Suppl 1():S115-8. PubMed ID: 12019844
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of USPIO-enhanced MRI and Gd-DTPA enhancement during the subacute stage of focal cerebral ischemia in rats.
    Yang YM; Feng X; Yin le K; Li CC; Jia J; Du ZG
    Acta Radiol; 2014 Sep; 55(7):864-73. PubMed ID: 24065200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal nodular hyperplasia of the liver: serial MRI with Gd-DOTA, superparamagnetic iron oxide, and Gd-EOB-DTPA.
    Kacl GM; Hagspiel KD; Marincek B
    Abdom Imaging; 1997; 22(3):264-7. PubMed ID: 9107647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between gadopentetate and feruglose (Clariscan)-enhanced MR-mammography: preliminary clinical experience.
    Daldrup-Link HE; Kaiser A; Link TM; Settles M; Helbich T; Werner M; Roberts TP; Rummeny EJ
    Acad Radiol; 2002 Aug; 9 Suppl 2():S343-7. PubMed ID: 12188270
    [No Abstract]   [Full Text] [Related]  

  • 13. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
    Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
    Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases.
    Kaufels N; Korn R; Wagner S; Schink T; Hamm B; Taupitz M; Schnorr J
    Invest Radiol; 2008 Jul; 43(7):496-503. PubMed ID: 18580332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI.
    Beaumont M; Lemasson B; Farion R; Segebarth C; Rémy C; Barbier EL
    J Cereb Blood Flow Metab; 2009 Oct; 29(10):1714-26. PubMed ID: 19584891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of liver-specific MRI contrast agents in rats with hepatitis and cirrhosis.
    Kato N; Takahashi M; Ihara S; Tsujimoto T; Miyazawa T
    Acad Radiol; 1998 Apr; 5 Suppl 1():S83-5. PubMed ID: 9561051
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional magnetic resonance imaging of the kidney using macromolecular contrast agents.
    Choyke PL; Kobayashi H
    Abdom Imaging; 2006; 31(2):224-31. PubMed ID: 16283582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor microvascular changes to anti-angiogenic treatment assessed by MR contrast media of different molecular weights.
    Roberts TP; Turetschek K; Preda A; Novikov V; Moeglich M; Shames DM; Brasch RC; Weinmann HJ
    Acad Radiol; 2002 Aug; 9 Suppl 2():S511-3. PubMed ID: 12188324
    [No Abstract]   [Full Text] [Related]  

  • 19. Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment.
    Claes A; Gambarota G; Hamans B; van Tellingen O; Wesseling P; Maass C; Heerschap A; Leenders W
    Int J Cancer; 2008 May; 122(9):1981-6. PubMed ID: 18081012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI susceptometry: image-based measurement of absolute susceptibility of MR contrast agents and human blood.
    Weisskoff RM; Kiihne S
    Magn Reson Med; 1992 Apr; 24(2):375-83. PubMed ID: 1569876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.